373 related articles for article (PubMed ID: 36045675)
21. Are tumours angiogenesis-dependent?
Verheul HM; Voest EE; Schlingemann RO
J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
[TBL] [Abstract][Full Text] [Related]
22. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
23. Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
Weiss A; van Beijnum JR; Bonvin D; Jichlinski P; Dyson PJ; Griffioen AW; Nowak-Sliwinska P
J Cell Mol Med; 2014 Mar; 18(3):480-91. PubMed ID: 24450440
[TBL] [Abstract][Full Text] [Related]
24. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
De Bock K; Cauwenberghs S; Carmeliet P
Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
[TBL] [Abstract][Full Text] [Related]
25. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
Jászai J; Schmidt MHH
Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
[TBL] [Abstract][Full Text] [Related]
26. Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity.
Tzeng HT; Huang YJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901858
[TBL] [Abstract][Full Text] [Related]
27. Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.
Kes MMG; Van den Bossche J; Griffioen AW; Huijbers EJM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188427. PubMed ID: 32961257
[TBL] [Abstract][Full Text] [Related]
28. Tumour vessel remodelling: new opportunities in cancer treatment.
Ganss R
Vasc Biol; 2020; 2(1):R35-R43. PubMed ID: 32923973
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid-mediated effects on angiogenesis in solid tumors.
Martens B; Drebert Z
J Steroid Biochem Mol Biol; 2019 Apr; 188():147-155. PubMed ID: 30654109
[TBL] [Abstract][Full Text] [Related]
30. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicle-mediated regulation of tumor angiogenesis- implications for anti-angiogenesis therapy.
Zhang S; Yang J; Shen L
J Cell Mol Med; 2021 Mar; 25(6):2776-2785. PubMed ID: 33586248
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer.
Choi SH; Yoo SS; Lee SY; Park JY
Arch Pharm Res; 2022 Apr; 45(4):263-279. PubMed ID: 35449345
[TBL] [Abstract][Full Text] [Related]
33. Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies.
Abou Khouzam R; Brodaczewska K; Filipiak A; Zeinelabdin NA; Buart S; Szczylik C; Kieda C; Chouaib S
Front Immunol; 2020; 11():613114. PubMed ID: 33552076
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.
Yetkin-Arik B; Kastelein AW; Klaassen I; Jansen CHJR; Latul YP; Vittori M; Biri A; Kahraman K; Griffioen AW; Amant F; Lok CAR; Schlingemann RO; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188446. PubMed ID: 33058997
[TBL] [Abstract][Full Text] [Related]
35. Targeting the vasculature of tumours: combining VEGF pathway inhibitors with radiotherapy.
Kanthou C; Tozer G
Br J Radiol; 2019 Jan; 92(1093):20180405. PubMed ID: 30160184
[TBL] [Abstract][Full Text] [Related]
36. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
37. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.
Schaaf MB; Garg AD; Agostinis P
Cell Death Dis; 2018 Jan; 9(2):115. PubMed ID: 29371595
[TBL] [Abstract][Full Text] [Related]
38. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
Carmeliet P; Jain RK
Nat Rev Drug Discov; 2011 Jun; 10(6):417-27. PubMed ID: 21629292
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic options to target angiogenesis in human malignancies.
Herbst RS
Expert Opin Emerg Drugs; 2006 Nov; 11(4):635-50. PubMed ID: 17064223
[TBL] [Abstract][Full Text] [Related]
40. Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment.
Schito L
Am J Physiol Regul Integr Comp Physiol; 2018 Dec; 315(6):R1072-R1084. PubMed ID: 30183339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]